Treatment of haemoglobinopathies and allied disorders. Report of a WHO Scientific Group.
D000755:Anemia, Sickle Cell / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D001803:Blood Transfusion; D005260:Female; D005817:Genetic Counseling; D005954:Glucosephosphate Dehydrogenase / Q000097:blood; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics / Q000628:therapy*; D006453:Hemoglobinopathies / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D006455:Hemoglobins, Abnormal / Q000032:analysis; D006801:Humans; D011247:Pregnancy; D011379:Prognosis; D013789:Thalassemia / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics
D006455:Hemoglobins, Abnormal; D005954:Glucosephosphate Dehydrogenase